TNFRSF8 and non-Hodgkin lymphoma: There was no significant difference between the HL and CD30-positive NHL groups for either parameter (Mann–Whitney U-Test: percentage of CD30+ cells p = 0.095; double positivity among CD30+ cells p = 0.408).